We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$144B
AUM Growth
+$2.8B
(+2%)
Cap. Flow
-$5.9B
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
347
New
10
Increased
58
Reduced
237
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$187M |
| 2 |
Intel
INTC
|
+$174M |
| 3 |
Aurora
AUR
|
+$114M |
| 4 |
Alibaba
BABA
|
+$86.2M |
| 5 |
Pulmonx
LUNG
|
+$72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$763M |
| 2 |
Tesla
TSLA
|
+$478M |
| 3 |
Adobe
ADBE
|
+$327M |
| 4 |
Microsoft
MSFT
|
+$319M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 26% |
| 3 | Industrials | 11.45% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Financials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.07T
| $8.2B | 5.68% |
29,690,681
-3,010,305
| -9% | -$763M |
|
|
2
Microsoft
MSFT
$2.84T
| $5.81B | 4.02% |
17,267,545
-984,910
| -5% | -$319M |
|
3
Micron Technology
MU
$1.04T
| $3.84B | 2.66% |
41,210,676
-2,143,470
| -5% | -$167M |
|
4
Biogen
BIIB
$29.9B
| $3.78B | 2.62% |
15,757,405
-501,510
| -3% | -$129M |
|
|
5
Tesla
TSLA
$1.24T
| $3.77B | 2.61% |
10,697,520
-1,424,790
| -12% | -$478M |
|
|
6
Adobe
ADBE
$89.5B
| $3.77B | 2.61% |
6,640,698
-522,335
| -7% | -$327M |
|
7
Amgen
AMGN
$203B
| $3.55B | 2.46% |
15,776,155
-306,532
| -2% | -$64.7M |
|
8
Texas Instruments
TXN
$255B
| $3.45B | 2.39% |
18,307,352
-1,148,035
| -6% | -$220M |
|
9
FedEx
FDX
$74.5B
| $3.41B | 2.36% |
13,195,532
-418,950
| -3% | -$101M |
|
|
10
Alphabet (Google) Class A
GOOGL
$3.91T
| $3.36B | 2.33% |
23,214,780
-1,687,300
| -7% | -$243M |
|
11
KLA
KLAC
$275B
| $3.34B | 2.31% |
77,641,740
-2,433,600
| -3% | -$93.9M |
|
12
Sony
SONY
$123B
| $3.31B | 2.29% |
131,117,875
-8,157,060
| -6% | -$194M |
|
13
Thermo Fisher Scientific
TMO
$211B
| $2.74B | 1.9% |
4,105,102
-196,360
| -5% | -$123M |
|
14
AstraZeneca
AZN
$263B
| $2.72B | 1.88% |
23,345,250
-787,875
| -3% | -$92.7M |
|
15
Wells Fargo
WFC
$261B
| $2.38B | 1.65% |
49,697,175
-253,490
| -0.5% | -$12.5M |
|
|
SCHW
16
Charles Schwab
SCHW
$177B
| $2.38B | 1.65% |
28,312,764
-753,700
| -3% | -$61M |
|
17
Southwest Airlines
LUV
$22.1B
| $2.33B | 1.61% |
54,290,429
-1,666,335
| -3% | -$78.2M |
|
|
18
Alphabet (Google) Class C
GOOG
$3.9T
| $2.25B | 1.56% |
15,571,440
-906,900
| -6% | -$131M |
|
|
19
Alibaba
BABA
$269B
| $2.07B | 1.43% |
17,384,317
+591,700
| +4% | +$86.2M |
|
|
20
Intel
INTC
$466B
| $2.03B | 1.4% |
39,401,295
+3,405,750
| +9% | +$174M |
|
21
JPMorgan Chase
JPM
$939B
| $1.82B | 1.26% |
11,470,229
-798,275
| -7% | -$131M |
|
22
NetApp
NTAP
$32.9B
| $1.68B | 1.16% |
18,267,904
-2,556,844
| -12% | -$230M |
|
23
Boston Scientific
BSX
$65.8B
| $1.62B | 1.12% |
38,118,619
-1,488,690
| -4% | -$62.6M |
|
24
Novartis
NVS
$295B
| $1.59B | 1.1% |
18,165,590
-896,060
| -5% | -$74.4M |
|
25
Aecom
ACM
$9.07B
| $1.58B | 1.09% |
20,450,396
-833,670
| -4% | -$58.5M |
|
Similar funds
Primecap Management's Q4 2021 Portfolio in Review
As of Q4 2021, Primecap Management held 347 positions worth $144B, up 2% from $142B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management withdrew a net $5.9B in Q4 2021, closing 5 positions and reducing 237 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Aurora worth $116M.
- Primecap Management's largest Q4 2021 buy was Aurora: 10,279,870 shares worth $116M.
- Primecap Management added most to Bristol-Myers Squibb in Q4 2021, an estimated $187M increase.
- Primecap Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $763M.
- Primecap Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $10M.
- Primecap Management's ten largest holdings make up 30% of its $144B portfolio in Q4 2021.
- Primecap Management opened 10 new positions and closed 5 in Q4 2021.
- Primecap Management's portfolio value rose 2% quarter-over-quarter to $144B.
Based on Primecap Management's 13F filing for Q4 2021, filed 11 Feb 2022.